SALICYLIC ACID
This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.
Global evidence snapshot
The resolved identity has matching regulatory evidence in 9 of 13 indexed market datasets: 12 country records and 1 EU Annex records. Every result and evidence gap is listed below.
Resolved substance identity
Salicylic acid
Inventory restriction note: III/98 V/3
12 matched or reported names
Regulatory evidence in all 13 markets
Open each matched record for its scope, concentration, conditions, warnings and official source version.
Swipe or scroll horizontally to see dataset coverage and next actions.
| Market | Result | Records | Dataset | Meaning / next action |
|---|---|---|---|---|
| European Union EU | Restricted | 1Open record 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | Review every linked record and exact conditions. |
| Great Britain GB | Restricted | 2Open record 1Open record 2 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | Review every linked record and exact conditions. |
| Canada CA | Restricted | 1Open record 1 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | Review every linked record and exact conditions. |
| New Zealand NZ | Restricted | 2Open record 1Open record 2 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | Review every linked record and exact conditions. |
| ASEAN ASEAN | Restricted | 2Open record 1Open record 2 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Review every linked record and exact conditions. |
| China CN | No local match | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | Restricted | 1Open record 1 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | Review every linked record and exact conditions. |
| South Korea KR | Restricted | 2Open record 1Open record 2 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Review every linked record and exact conditions. |
| United States US | No local match | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | No local match | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | No local match | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Restricted | 1Open record 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | Review every linked record and exact conditions. |
| Saudi Arabia SA | Restricted | 1Open record 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | Review every linked record and exact conditions. |
Matching market records and conditions
Great Britain
GB retained Regulation 1223/2009 schedules, effective 15 August 2026Canada
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025New Zealand
Cosmetic Products Group Standard schedules effective 1 January 2026ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026Japan
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshotSouth Korea
MFDS Notice 2026-19, effective 18 March 2026India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026Exact Annex II–VI evidence
SALICYLIC ACID
Product scope: (a) Rinse-off hair products (b) Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant (c) Body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant
Maximum concentration: (a) 3.0% (b) 2.0% (c) 0.5%
Restrictions: (a) (b) (c) Not to be used in preparations for children under 3 years of age. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products. For purposes other than inhibiting the development of micro-organisms in the product. This purpose has to be apparent from the presentation of the product. These levels are inclusive of any use of salicylic acid.
Warnings: (a) (b) (c) Not to be used for children under 3 years of age* * Solely for products which might be used for children under 3 years of age.
Chemical identity and properties

Betaine salicylate
- IUPAC name
- carboxymethyl(trimethyl)azanium;2-carboxyphenolate
- Molecular formula
- C12H17NO5
- Molecular weight
- 255.27 g/mol
- Exact mass
- 255.11067264 Da
- Topological polar surface area
- 97.7 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 5
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
4 more reported names
External database identifiers
- EPA DTXSID:DTXSID60170177
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

(T-4)-Bis(2-(hydroxy-kappaO)benzoato-kappaO)magnesium
Magnesium salicylate is a non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain. It is available in several over-the-counter (OTC) formulations. Though the recommended doseage is 1160 mg every six hours, per package directions of the Doan's OTC brand (580 mg magnesium salicylate tetrahydrate, equivalent to 934.4 mg anhydrous magnesium salicylate), effective pain relief is often found with a half dosage, with reduced anti-inflammatory results. — DrugBank
- IUPAC name
- magnesium bis(2-carboxyphenolate)
- Molecular formula
- C14H10MgO6
- Molecular weight
- 298.53 g/mol
- Exact mass
- 298.0327797 Da
- Topological polar surface area
- 121.0 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 6
- Covalent units
- 3
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEMBL:CHEMBL2106755
- EPA DTXSID:DTXSID00889392
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Trolamine Salicylate
Trolamine salicylate is an organic compound or a salt formed between triethanolamine and salicylic acid. Triethanolamine neutralizes the acidity of the salicylic acid. It is a topical analgesic used for temporary relief of minor pain associated with arthritis, simple backache, muscle strains, sprains, and bruises. Unlike other topical analgesics, trolamine salicylate has no distinct odor which improves patient acceptability. It also displays low systemic absorption upon dermal or topical administration and has low skin irritant properties. As with other salicylates, trolamine salicylate is an inhibitor of cyclo-oxygenase (COX) enzymes with no reported selectivity towards a specific enzyme isoform. Trolamine salicylate serves as an active ingredient in topical over-the-counter products for temporary management of mild to moderate muscular and joint pains. — DrugBank
- IUPAC name
- 2-[bis(2-hydroxyethyl)amino]ethanol;2-hydroxybenzoic acid
- Molecular formula
- C13H21NO6
- Molecular weight
- 287.31 g/mol
- Exact mass
- 287.13688739 Da
- Topological polar surface area
- 121.0 Ų
- Hydrogen-bond donors
- 5
- Hydrogen-bond acceptors
- 7
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEMBL:CHEMBL2107288
- EPA DTXSID:DTXSID4047969
- PubMed:24312851
- PubMed:19078236
- PubMed:18796932
- PubMed:8876850
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Sodium Salicylate
Sodium salicylate is an organic molecular entity. — ChEBI
- IUPAC name
- sodium 2-hydroxybenzoate
- Molecular formula
- C7H5NaO3
- Molecular weight
- 160.10 g/mol
- Exact mass
- 160.01363830 Da
- Topological polar surface area
- 60.4 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 3
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:9180
- ChEMBL:CHEMBL447868
- EPA DTXSID:DTXSID5021708
- PubMed:29117515
- PubMed:23652544
- PubMed:23504962
- PubMed:22898132
- PubMed:21303813
- PubMed:19767084
- PubMed:19173110
- PubMed:19026709
- PubMed:18560754
- PubMed:18483001
- PubMed:17568627
- PubMed:17561093
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Potassium Salicylate
The Panel concluded that the following ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA)...Potassium Salicylate... — Cosmetic Ingredient Review (CIR)
- IUPAC name
- potassium 2-hydroxybenzoate
- Molecular formula
- C7H5KO3
- Molecular weight
- 176.21 g/mol
- Exact mass
- 175.98757550 Da
- Topological polar surface area
- 60.4 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 3
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
11 more reported names
External database identifiers
- ChEMBL:CHEMBL3707342
- EPA DTXSID:DTXSID9060366
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Salicylic acid monoethanolamine
Based on the available information, the CIR Expert Panel concluded that ... MEA-Salicylate... safe as used when formulated to be avoid skin ittiration and when formulated to avoid increasing the skin's sun sensitivity,or, when increased sun sensitivity would be expected, directions for use induce the daily use of sun protection. — Cosmetic Ingredient Review (CIR)
- IUPAC name
- 2-aminoethanol;2-hydroxybenzoic acid
- Molecular formula
- C9H13NO4
- Molecular weight
- 199.20 g/mol
- Exact mass
- 199.08445790 Da
- Topological polar surface area
- 104.0 Ų
- Hydrogen-bond donors
- 4
- Hydrogen-bond acceptors
- 5
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
7 more reported names
External database identifiers
- EPA DTXSID:DTXSID80208587
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Salicylic Acid
Salicylic acid is a monohydroxybenzoic acid that is benzoic acid with a hydroxy group at the ortho position. It is obtained from the bark of the white willow and wintergreen leaves. It has a role as an antiinfective agent, an antifungal agent, a plant hormone, a keratolytic drug, an EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor, a plant metabolite and an algal metabolite. It is a conjugate acid of a salicylate. — ChEBI
- IUPAC name
- 2-hydroxybenzoic acid
- Molecular formula
- C7H6O3
- Molecular weight
- 138.12 g/mol
- Exact mass
- 138.031694049 Da
- XLogP3
- 2.3
- Topological polar surface area
- 57.5 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 3
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Calcium Salicylate
The Panel concluded that the following ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA)...Calcium Salicylate... — Cosmetic Ingredient Review (CIR)
- IUPAC name
- calcium bis(2-carboxyphenolate)
- Molecular formula
- C14H10CaO6
- Molecular weight
- 314.30 g/mol
- Exact mass
- 314.0103289 Da
- Topological polar surface area
- 121.0 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 6
- Covalent units
- 3
- Defined stereocentres
- 0
Also known as
5 more reported names
External database identifiers
- EPA DTXSID:DTXSID60890489
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Additional authoritative substance research
Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight
Take this record further
Official source and scope
Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.
Open official Decision